News

Leo Lens Pharma Expands Its Scientific Advisory Board

External Thought Leaders to Help Guide Progress on Company’s Proprietary Continuous Ocular Drug Delivery Portfolio FOR IMMEDIATE RELEASE SAN DIEGO, CA, USA (Business Wire August 5th, 2020) – Today, Leo Lens Pharma, an emerging San Diego-based pharmaceutical company focused on helping protect sight, announces the expansion of its Scientific Advisory Board (SAB) that now comprises […]

Leo Lens Pharma Excited to be a Presenting Company at OTS 2020

Leo Lens Pharma Excited to Have Its Lead Asset Ready for Human Clinical Evaluation

Patented product for the novel treatment of glaucoma is IND-ready

Leo Lens Pharma Proud to Be Selected as a Connect 2020 Cool Company

Leo Lens Pharma Appoints Dan Myers CEO

Accomplished Ophthalmic Executive to Lead Company in Its Next Phase

Myopia Management Focus of Pipeline Expansion for Leo Lens Pharma

Leo Lens Pharma Strengthens its Pipeline with New IP Protection for a Unique Atropine-based Myopia Management Solution February 19, 2020 08:51 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) announced it received a notice of allowance from the USPTO for a patent for the use […]

Biocom Member Spotlight: Interview with Kokila & Praful Doshi, Co-Founders of Leo Lens Technology

Leo Lens was featured in a Member Spotlight article from Biocom. Read it here: https://www.biocom.org/corporate-newsletter/newsletter-article/?article=Biocom-Member-Spotlight-Interview-with-Kokila-and-Praful-Doshi-Co-Founders-of-Leo-Lens-Technology

Leo Lens Selected as Presenting Company at Octane MTIF 2018

Leo Lens was selected from over 150 companies to be a presenting company at Octane’s 2018 Medical Technology Innovation Forum. For more information on the event go to www.mtif2018.com.